Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,350
Out of 4,944 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $160.78 | +8.84% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $83.00 | -27.71% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $17.64 | +296.83% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $113.06 | +1.72% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $87.49 | -8.56% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.20 | +6,150.00% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $160.78
Upside: +8.84%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $83.00
Upside: -27.71%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $17.64
Upside: +296.83%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $113.06
Upside: +1.72%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $87.49
Upside: -8.56%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.20
Upside: +6,150.00%